de la Morena-Barrio B, Palomo A, Padilla J, Martin-Fernandez L, Rojo-Carrillo JJ, Cifuentes R, Bravo-Perez C, Garrido-Rodriguez P, Minano A, Rubio AM, Pagan J, Llamas M, Vicente V, Vidal F, Lozano ML, Corral J, de la Morena-Barrio ME. Impact of genetic structural variants in factor XI deficiency: identification, accurate characterization, and inferred mechanism by long-read sequencing. J Thromb Haemost. 2023 Jul;21(7):1779-1788. doi: 10.1016/j.jtha.2023.03.009. Epub 2023 Mar 20. PubMed PMID: 36940803.
AÑO: 2023; IF: 5.5
|
Pagan-Escribano J, Corral J, Minano A, Padilla J, Roldan V, Hernandez-Vidal MJ, Lozano J, de la Morena-Barrio I, Vicente V, Lozano ML, Herranz MT, de la Morena-Barrio ME. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases. Int J Mol Sci. 2023 Nov 13;24(22):16270. doi: 10.3390/ijms242216270. PubMed PMID: 38003459; PubMed Central PMCID: PMC10670960.
AÑO: 2023; IF: 4.9
|
Lozano ML. Expanding therapeutic options for patients with primary immune thrombocytopenia. Lancet Haematol. 2023 Jun;10(6):e390-e391. doi: 10.1016/S2352-3026(23)00063-7. Epub 2023 Apr 4. No abstract available. PubMed PMID: 37028434.
AÑO: 2023; IF: 15.4
|
Hurtado-Navarro L, Cuenca-Zamora EJ, Zamora L, Bellosillo B, Such E, Soler-Espejo E, Martinez-Banaclocha H, Hernandez-Rivas JM, Marco-Ayala J, Martinez-Alarcon L, Linares-Latorre L, Garcia-Avila S, Amat-Martinez P, Gonzalez T, Arnan M, Pomares-Marin H, Carreno-Tarragona G, Chen-Liang TH, Herranz MT, Garcia-Palenciano C, Morales ML, Jerez A, Lozano ML, Teruel-Montoya R, Pelegrin P, Ferrer-Marin F. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. Cell Rep Med. 2023 Dec 19;4(12):101329. doi: 10.1016/j.xcrm.2023.101329. PubMed PMID: 38118408; PubMed Central PMCID: PMC10772462.
AÑO: 2023; IF: 11.7
|
de Los Reyes-Garcia AM, Zapata-Martinez L, Aguila S, Lozano ML, Martinez C, Gonzalez-Conejero R. microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation. Front Cardiovasc Med. 2023 Feb 21;10:1135127. doi: 10.3389/fcvm.2023.1135127. eCollection 2023. PubMed PMID: 36895835; PubMed Central PMCID: PMC9988920.
AÑO: 2023; IF: 2.8
|